Our COO, Sabrina Ramkellawan will be speaking at the DIA conference in Quebec on November 14-15, 2025. She will be speaking on the Equity, Diversity, Inclusion and Accessibility (EDIA) in Trials track. Her talk "Strategies to Bridge the Diversity, Equity and Inclusion Gap in Clinical Trials" including the use of Artificial Intelligence to facilitate recruitment and retention. The track will also include other speaker including Kim Meeking from Queering Cancer speaking on Queering Clinical Trials: Cultural Sensitivity from Bench to Bedside, Munaza Jamil from McMaster University speaking on Bridging the Gap: Advancing New Immigrant Participation in Clinical Trials and our track will be moderated by Rebecca Barnes from N2 Network of Networks.